Morie A. Gertz, MD of Mayo Clinic discusses the roles of proteasome inhibitors and immunomodulatory agents in Waldenstroms Macroglobulinemia at Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content